Article
Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype--implications for the role of transglutaminase in coeliac disease.
BMC immunology - 16 Apr 2012
Dalleywater William J, Chau David Y S, Ghaemmaghami Amir M
Abstract excerpt
Dendritic cells (DCs) are part of the innate immune system with a key role in initiating and modulating T cell mediated immune responses. Coeliac disease is caused by inappropriate activation of such a response leading to small intestinal inflammation when gluten is ingested. Tissue transglutaminase, an extracellular matrix (ECM) protein, has an established role in coeliac disease; however, little work to date...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
